Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Calgary
$105,000.00
Fluorescence Spectroscopy of Islet Amyloid Polypeptide to Better Understand Diabetic Kidney Disease Pathogenesis and Improve Diagnostic Testing
FY 2022-23
Summary
Diabetes occurs in part due to damaged insulin-producing cells in the pancreas. As the disease progresses, patients often develop diabetic kidney disease (DKD). Due to the ongoing obesity epidemic, diabetes is on the rise around the world and will affect over 600 million people worldwide by 2040. Even though diabetes is already a leading cause of kidney disease, why DKD develops is not well understood.
A protein known as islet amyloid polypeptide (IAPP) plays a significant role in damaging insulin-producing cells. Normally, IAPP is released with insulin to suppress food intake and promote emptying of the stomach. However, in diabetic patients, IAPP tends to clump into a toxic form in the pancreas causing further damage and exacerbating the disease. Due to these effects and the fact that IAPP is found in the urine of diabetic patients, toxic forms of IAPP could be major contributors to kidney damage as in the pancreas.
Our team has developed advanced microscopic techniques using dyes that change color when they detect toxic clumped proteins, like IAPP. By analyzing such changes, proteins that are toxic and responsible for tissue injury can be identified. Recently, we have shown that these methods can detect kidney diseases related to other types of clumped proteins, supporting the use of these techniques in studying DKD.
Our study will use fluorescent dyes to stain kidney and pancreatic samples of patients with diabetes. Quantitative analyses of the dye properties can then be undertaken to study IAPP in the samples. We aim to use this technique to determine if IAPP in the urine of diabetic patients may be an early indicator of DKD. To diagnose DKD from a simple urine test would be a major advancement, as a needle biopsy of the kidney is currently required. This study will lead to improved diagnostic tests, a better understanding of why DKD develops, which patients are at greatest risk, and inform new ways to treat this common and serious complication of diabetes.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
475976
Name
Brandt Paula J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Fluorescence Spectroscopy of Islet Amyloid Polypeptide to Better Understand Diabetic Kidney Disease Pathogenesis and Improve Diagnostic Testing
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Biophysics; Diabetic Nephropathy; Fluorescence Spectroscopy; Renal Amyloidosis
Abstract
Diabetes occurs in part due to damaged insulin-producing cells in the pancreas. As the disease progresses, patients often develop diabetic kidney disease (DKD). Due to the ongoing obesity epidemic, diabetes is on the rise around the world and will affect over 600 million people worldwide by 2040. Even though diabetes is already a leading cause of kidney disease, why DKD develops is not well understood.
A protein known as islet amyloid polypeptide (IAPP) plays a significant role in damaging insulin-producing cells. Normally, IAPP is released with insulin to suppress food intake and promote emptying of the stomach. However, in diabetic patients, IAPP tends to clump into a toxic form in the pancreas causing further damage and exacerbating the disease. Due to these effects and the fact that IAPP is found in the urine of diabetic patients, toxic forms of IAPP could be major contributors to kidney damage as in the pancreas.
Our team has developed advanced microscopic techniques using dyes that change color when they detect toxic clumped proteins, like IAPP. By analyzing such changes, proteins that are toxic and responsible for tissue injury can be identified. Recently, we have shown that these methods can detect kidney diseases related to other types of clumped proteins, supporting the use of these techniques in studying DKD.
Our study will use fluorescent dyes to stain kidney and pancreatic samples of patients with diabetes. Quantitative analyses of the dye properties can then be undertaken to study IAPP in the samples. We aim to use this technique to determine if IAPP in the urine of diabetic patients may be an early indicator of DKD. To diagnose DKD from a simple urine test would be a major advancement, as a needle biopsy of the kidney is currently required. This study will lead to improved diagnostic tests, a better understanding of why DKD develops, which patients are at greatest risk, and inform new ways to treat this common and serious complication of diabetes.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Brandt, Paula J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~